A Call to Action to Implement Effective COVID-19 Prevention and Screening of Individuals with Severe Intellectual Developmental and Autism Spectrum Disorders

A Baghdadli^{1

2}, M C Picot^{3

4}, S Miot^{3

5}, K Munir⁶

Affiliations

¹ Center of Excellence in Autism and Neurodevelopmental Disorders, University and CHU of Montpellier, Montpellier, France. rech-clinique-autisme@chu-montpellier.fr.
² Center of Resources in Autism, University and CHU of Montpellier, 39 Avenue Charles Flahaut, 34295, Montpellier Cedex 05, France. rech-clinique-autisme@chu-montpellier.fr.
³ Center of Excellence in Autism and Neurodevelopmental Disorders, University and CHU of Montpellier, Montpellier, France.
⁴ Clinical Research and Epidemiology Unit, University and CHU of Montpellier, 34000, Montpellier, France.
⁵ Geriatrics Department, Center of Excellence in Autism and Neurodevelopmental Disorders, University and CHU of Montpellier, 34000, Montpellier, France.
⁶ Developmental Medicine Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

A Baghdadli et al. J Autism Dev Disord. 2021 Jul.

. 2021 Jul;51(7):2566-2568.

doi: 10.1007/s10803-020-04719-6.

A Baghdadli^{1

2}, M C Picot^{3

4}, S Miot^{3

5}, K Munir⁶

¹ Center of Excellence in Autism and Neurodevelopmental Disorders, University and CHU of Montpellier, Montpellier, France. rech-clinique-autisme@chu-montpellier.fr.
² Center of Resources in Autism, University and CHU of Montpellier, 39 Avenue Charles Flahaut, 34295, Montpellier Cedex 05, France. rech-clinique-autisme@chu-montpellier.fr.
³ Center of Excellence in Autism and Neurodevelopmental Disorders, University and CHU of Montpellier, Montpellier, France.
⁴ Clinical Research and Epidemiology Unit, University and CHU of Montpellier, 34000, Montpellier, France.
⁵ Geriatrics Department, Center of Excellence in Autism and Neurodevelopmental Disorders, University and CHU of Montpellier, 34000, Montpellier, France.
⁶ Developmental Medicine Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

1. Hwang YI, Foley KR, Trollor JN. Aging well on the autism spectrum: An examination of the dominant model of successful aging. Journal of Autism and Developmental Disorders. 2020;50(7):2326–2335. doi: 10.1007/s10803-018-3596-8. - DOI - PubMed
1. Lindly OJ, Zuckerman KE, Kuhlthau KA. Healthcare access and services use among US children with autism spectrum disorder. Autism. 2019;23(6):1419–1430. doi: 10.1177/1362361318815237. - DOI - PMC - PubMed
1. Masi A, Breen EJ, Alvares GA, Glozier N, Hickie IB, Hunt A, et al. Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder. Molecular Autism. 2017;8:63. doi: 10.1186/s13229-017-0176-2. - DOI - PMC - PubMed
1. Miot S, Akbaraly T, Michelon C, Couderc S, Crepiat S, Loubersac J, et al. Comorbidity burden in adults with autism spectrum disorders and intellectual disabilities-A Report From the EFAAR (Frailty Assessment in Ageing Adults With Autism Spectrum and Intellectual Disabilities) Study. Front Psychiatry. 2019;10:617. doi: 10.3389/fpsyt.2019.00617. - DOI - PMC - PubMed
1. Schoufour JD, Echteld MA, Boonstra A, Groothuismink ZM, Evenhuis HM. Biochemical measures and frailty in people with intellectual disabilities. Age and Ageing. 2016;45(1):142–148. doi: 10.1093/ageing/afv152. - DOI - PubMed